JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
GlobeNewswire
*Ad hoc announcement pursuant to Art. 53 LR*
· Idorsia receives a positive opinion from the Committee for Medicinal..
*Ad hoc announcement pursuant to Art. 53 LR*
· Idorsia receives a positive opinion from the Committee for Medicinal..
MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- *Panbela Therapeutics, Inc. (NASDAQ:PBLA), *a clinical stage company developing..
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Biotechnology 2019-2024" report has been added to *..